Overview


Atrophic (Advanced) Dry Age-related Macular Degeneration (AMD)
 
Feasibility Study of Compensation for blindness with the PRIMA system in patients with dry age related macular degeneration."

Pixium Vision is developing PRIMA system to demonstrate that the wireless sub-retinal implant will provide patients with improved perception, thus offering improved quality of life.

ClinicalTrials.gov : https://clinicaltrials.gov/ct2/show/NCT03333954?term=NCT03333954&recrs=ab&rank=1

_________________________________________________________________________________________________________________________

"Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (IRIS 2)."

Pixium Vision is developing IRIS® to demonstrate that the Epi-retinal implant will provide patients with improved perception, thus offering more autonomy and a better quality of life.

The IRIS® system currently in clinical trial has been designed so that RP patients can “perceive” objects by recognising their size, position, orientation and movement.

The objective of this advanced epi-retinal Bionic Vision Restoration System (VRS) is to enable patients to identify and pick up a cup, shake hands and recognise certain objects such as a plate, a table, a door or a chair.

ClinicalTrials.gov : https://www.clinicaltrials.gov/ct2/show/NCT02670980?term=Pixium&rank=1

Enrollment of this clinical trial has been closed. Please visit our website frequently to be informed about new clinical trials.